Angelini Pharma Archives | Be Korea-savvy

Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO

CEO of family company Angelini Industries will also lead the pharmaceutical company from today, bringing strong leadership experience and strategic vision ROME, Jan. 21, 2026 (Korea Bizwire) – Angelini Pharma, part of the multinational privately owned industrial group Angelini Industries, today announced the appointment of Sergio Marullo di Condojanni as Chief Executive Officer. He has [...]

Ovid Therapeutics and Angelini Pharma Enter into Exclusive License Agreement to Develop, Manufacture and Commercialize OV101 for the Treatment of Angelman Syndrome in Europe

NEW YORK and ROME, July 13 (Korea Bizwire) — Ovid Therapeutics Inc. (NASDAQ: OVID, hereinafter “Ovid”), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, and Angelini Pharma S.p.A. (hereinafter “Angelini Pharma”), an Italian family-owned pharmaceutical company committed to helping patients with a constant and prevalent focus on [...]